These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2683518)

  • 21. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recombinant antibodies to tick-borne encephalitis virus].
    Nikolenko GN; Protopopova EV; Il'ichev AA; Konovalova SN; Karpenko LI; Loktev VB; Poryvaeva VA; Tikunova NV
    Vopr Virusol; 2002; 47(5):31-6. PubMed ID: 12522967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ELISA for IgM and IgG antibodies against tick-borne encephalitis virus: quantification and standardization of results.
    Hofmann H; Heinz FX; Dippe H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Nov; 255(4):448-55. PubMed ID: 6362274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid serological diagnosis of tick-borne encephalitis by means of enzyme immunoassay.
    Grubhoffer L; Krivanec K; Kopecký J; Tomková E
    Folia Parasitol (Praha); 1988; 35(2):181-7. PubMed ID: 3049275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Isolation of split and whole-virion tick-borne encephalitis vaccines in an experiment and the characteristics of their immunogenic and antigenic properties].
    Osipova EG; Solianik RG; Fedorov IuV; Tymchishin PN
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):50-3. PubMed ID: 3687295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effectiveness of a method for the determination of early specific immunoglobulins in the hemagglutination inhibition reaction for diagnosing tick-borne encephalitis].
    Pivanova GP; Karavanov AS; Bannova GG; Nekliudova Vm; Beloborodova NM
    Vopr Virusol; 1987; 32(2):245-8. PubMed ID: 3604189
    [No Abstract]   [Full Text] [Related]  

  • 27. A putative host cell receptor for tick-borne encephalitis virus identified by anti-idiotypic antibodies and virus affinoblotting.
    Kopecký J; Grubhoffer L; Kovár V; Jindrák L; Vokurková D
    Intervirology; 1999; 42(1):9-16. PubMed ID: 10393498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
    Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
    BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationships between the content of circulating immune complexes, the concentration of serum immunoglobulins and the titers of specific antibodies in patients with tick-borne encephalitis].
    Ivanov VG; Ivanov GG; Barsukov AK; Kuznetsova AI
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):93-5. PubMed ID: 15346962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Subunit immunogen of the tick-borne encephalitis virus. The immunological characteristics of glycoprotein V3 from 2 antigenic types of tick-borne encephalitis virus].
    Chumakov MP; Rubin SG; Kusov IuIu; Semashko IV; Sal'nikov IaA
    Vopr Virusol; 1984; 29(6):701-6. PubMed ID: 6528577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A method for rapid and high-yield production of the tick-borne encephalitis virus E and DIII recombinant proteins in E. coli with preservation of the antigenic properties.
    Rizzo S; Mora-Cárdenas E; Faoro V; D'Agaro P; Edomi P; Marcello A; Sblattero D
    Ticks Tick Borne Dis; 2019 Jun; 10(4):935-941. PubMed ID: 31072731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparative assessment of two immunoenzyme test systems for detecting antibodies to tick-borne encephalitis virus].
    Matveev LE; Karavanov AS; Rubin SG; Semashko IV; Tsekhanovskaia NA; Pressman EK
    Vopr Virusol; 1989; 34(4):488-91. PubMed ID: 2686164
    [No Abstract]   [Full Text] [Related]  

  • 35. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunological indices of human vaccination against tick-borne encephalitis using inactivated preparations with a varying concentration of the viral antigen].
    El'bert LB; Pervikov IuV; Krutianskaia GL; Krasil'nikov IV; Grachev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):89-92. PubMed ID: 7293574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. To the antigenic classification of some viruses from the tick-borne encephalitis complex by monoclonal antibodies.
    Gresíková M; Sekeyová M
    Acta Virol; 1990 Feb; 34(1):90-4. PubMed ID: 1975730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulins to tick-borne encephalitis in the cerebrospinal fluid of man.
    Hofmann H; Frisch-Niggemeyer W; Heinz F; Kunz C
    J Med Virol; 1979; 4(3):241-5. PubMed ID: 536745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of tick-borne encephalitis virus in monkeys. VII. Some features of the immune response.
    Pogodina VV; Bochkova NG; Levina LS
    Acta Virol; 1984 Sep; 28(5):407-15. PubMed ID: 6151355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vaccines, immunoglobulins, and test systems for the prevention and diagnosis of tick-borne encephalitis].
    Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP
    Vopr Virusol; 2007; 52(6):30-6. PubMed ID: 18050715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.